![Patricia Ohana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patricia Ohana
Hoofd Techniek/Wetenschap/O&O bij The Hebrew University of Jerusalem
Actieve functies van Patricia Ohana
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The Hebrew University of Jerusalem | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Patricia Ohana
Eerdere bekende functies van Patricia Ohana
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Hoofd Techniek/Wetenschap/O&O | - | 14-10-2010 |
Corporate Officer/Principal | 14-10-2010 | - |
Statistieken
Internationaal
Verenigde Staten | 2 |
Israël | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
- Beurs
- Insiders
- Patricia Ohana
- Ervaring